V011-3442 Screening compound: 4-{4-[2-(4-cyclobutanecarbonylpiperazin-1-yl)pyrimidin-4-yl]phenyl}morpholine

V011-3442 Screening compound: 4-{4-[2-(4-cyclobutanecarbonylpiperazin-1-yl)pyrimidin-4-yl]phenyl}morpholine
V011-3442 Screening compound: 4-{4-[2-(4-cyclobutanecarbonylpiperazin-1-yl)pyrimidin-4-yl]phenyl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-3442
4-{4-[2-(4-cyclobutanecarbonylpiperazin-1-yl)pyrimidin-4-yl]phenyl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-3442

Molecular Formula

C23H29N5O2 (C23 H29 N5 O2)

Compound Name

4-{4-[2-(4-cyclobutanecarbonylpiperazin-1-yl)pyrimidin-4-yl]phenyl}morpholine

IUPAC name

4-{4-[2-(4-cyclobutanecarbonylpiperazin-1-yl)pyrimidin-4-yl]phenyl}morpholine

SMILES

O=C(C1CCC1)N(CC1)CCN1c1nc(-c(cc2)ccc2N2CCOCC2)ccn1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.839

Distribution Coefficient, logD

2.839

Water Solubility, LogSw

-2.91

Polar Surface Area

49.690

Acid Dissociation Constant (pKa)

21.15

Base Dissociation Constant (pKb)

3.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

V011-3442 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Soluble Diversity Library (15920 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V011-3442 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-3442?
Check Price and Availability of V011-3442, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-3442 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-3442
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-3442
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-3442 available by request